EpiQuik In Situ H3K9 Acetylation Assay Kit

The EpiQuik™ In Situ H3-K9 Acetylation Assay Kit is a convenient package of tools that allows the experimenter to measure in situ acetylation of histone H3-K9 at tremendously fast speeds and consistency, superior and safer than all other current methods. The kit is ready-to-use and provides all the essential components needed to carry out a successful assay experiment. The EpiQuik™ In Situ H3-K9 Acetylation Assay Kit is suitable for specifically measuring in situ histone H3-K9 acetylation using cultured adherent cells. The kit has the following advantages:

• Quick and efficient procedure, which can be finished within 3 hours.
• Innovative colorimetric assay without the need for radioactivity, electrophoresis, or chromatography.
• Measurement of in situ histone H3-K9 acetylation, with out the need to prepare cell lysates.
• Microplate format makes the assay suitable for high throughput analysis of agents that increases or inhibits H3-K9 acetylation.
• Simple, reliable, and consistent assay conditions.

Principle & Procedure
EpiQuik™ In Situ Histone H3-K9 Acetylation Assay Kit uses whole cell-based detection of acetylated H3-K9. In this assay, adherent cells are cultured in conventional 96-well microplates. After your experimental treatment, cells are fixed and permeabilized. The acetylated H3-K9 is then detected by a high affinity acetyl H3-K9 antibody. The ratio or amount of acetyl H3-K9 can be quantified through HRP conjugated secondary antibody-color development system and is proportional to the intensity of color development.

1. Chen M et. al. (September 2024). Histone deacetylase inhibition enhances extracellular vesicles from muscle to promote osteogenesis via miR-873-3p. Signal Transduct Target Ther. 9(1):256.
2. Man K et. al. (April 2023). Epigenetic Reprogramming via Synergistic Hypomethylation and Hypoxia Enhances the Therapeutic Efficacy of Mesenchymal Stem Cell Extracellular Vesicles for Bone Repair. Int J Mol Sci. 24(8)
3. Man K et. al. (January 2022). Controlled Release of Epigenetically-Enhanced Extracellular Vesicles from a GelMA/Nanoclay Composite Hydrogel to Promote Bone Repair. Int J Mol Sci. 23(2)
4. Man K et. al. (July 2021). MI192 induced epigenetic reprogramming enhances the therapeutic efficacy of human bone marrows stromal cells for bone regeneration. Bone. :116138.
5. Li B et. al. (March 2017). DICER1 regulates endometrial carcinoma invasion via histone acetylation and methylation. J Cancer. 8(6):933-939.